01 1Shionogi Pharma Co., Ltd.
01 1Cefiderocol Sulfate Tosylate
01 1Japan
NDC Package Code : 53044-005
Start Marketing Date : 2020-01-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Cefiderocol sulfate tosylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cefiderocol sulfate tosylate, including repackagers and relabelers. The FDA regulates Cefiderocol sulfate tosylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cefiderocol sulfate tosylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cefiderocol sulfate tosylate supplier is an individual or a company that provides Cefiderocol sulfate tosylate active pharmaceutical ingredient (API) or Cefiderocol sulfate tosylate finished formulations upon request. The Cefiderocol sulfate tosylate suppliers may include Cefiderocol sulfate tosylate API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cefiderocol sulfate tosylate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cefiderocol sulfate tosylate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cefiderocol sulfate tosylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cefiderocol sulfate tosylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cefiderocol sulfate tosylate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cefiderocol sulfate tosylate suppliers with NDC on PharmaCompass.
We have 1 companies offering Cefiderocol sulfate tosylate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
